Edwards Lifesciences Corp

Latest QuantConomy context for EW: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NYSE

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for EW. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for EW

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
earnings earnings release	neutral	40	Feb 10, 12:00 AM	EW filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-10. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
insider trade large sale	very bearish	38	May 27, 11:29 PM	BOBO DONALD E JR sold EW shares ($2.00M) - 23145 shares - [weak very bearish signal]
corporate event executive change	neutral	85	May 8, 08:15 PM	EW filed 8-K: Director or Officer Changes, Shareholder Vote Results - 1 material event - [very strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market	Exchange	Source	Asset record
EW	NYSE	alpaca	Edwards Lifesciences Corp
EW	NYSE	alphavantage	Edwards Lifesciences Corp
EW	NYSE	fmp	Edwards Lifesciences Corporation

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jul 10, 2026	Lippis Daniel J.	CVP, TAVR	exercise	619	$72.68	$44,989	4 on EDGAR
Jul 9, 2026	Mistras Theodora	CVP, Chief Financial Officer	grant	87,595	$0.00	$0	4 on EDGAR
Jul 7, 2026	Lippis Daniel J.	CVP, TAVR	other	377	$95.18	$35,883	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.